The Effect of Presence of Helicobacter pylori on the Severity and Clinical Course of Rosacea

  • Djuka J Ninkovic Univerzitetski Klinicki centar Klinika za kozne i polne bolesti Banja Luka
  • Vesna Gajanin
  • Nevena Kutlija
  • Igor Sladojevic
  • Svetozar Krivokuća
Keywords: Rosacea, Helicobacter pylori, drug effects

Abstract


Introduction: Rosacea is manifested by erythema and telangiectasias limited to the regions of cheeks, nose, chin and forehead. Data from the literature indicate a possi- ble causal relationship between Helicobacter pylori infection in the gastrointestinal tract and rosacea, which is confirmed by the improvement of symptoms and clinical picture of rosacea after administered Helicobacter pylori eradication therapy. The aim of the paper was to determine the frequency of Helicobacter pylori infection in patients with rosacea and to examine the effect of the therapy for eradication of infection of this microorganism on the clinical course of rosacea.

Methods: Sixty patients with a diagnosis of rosacea who were treated in 2018 at the Clinic for Skin and Venereal Diseases of the University Clinical Centre of Republic of Srpska were analysed. Patients were examined during their visit to a dermatologist (first week) and after applied therapy (sixth week). Subjects were divided into two groups - group I consisted of subjects in which, in addition to rosacea, the presence of Helicobacter pylori was registered and for whom the topical therapy and triple therapy for eradication of Helicobacter pylori were administered, and group II, which included subjects in which, in addition to rosacea, the presence of Helicobacter pylori was not registered and for whom only topical therapy was administered. Statistical processing was performed in the IBM SPSS Statistics 21 software package.

Results: Helicobacter pylori infection was registered in 45 % of patients. Statistical significance was determined between the presence of Helicobacter pylori infection and the presence of pustules in patients with rosacea (p = 0.027), with an occurrence of pustules significantly more frequent in patients belonging to group I (55.6 %) than in patients belonging to group II (24.2 %).

Conclusion: Therapy for eradicating Helicobacter pylori infection improves the clini- cal course of rosacea, especially in the stage of papules and pustules.

References

Culp B, Scheinfeld N. Rosacea: A review. P T 2009 Jan;34(1):38-45.

Goldberg DJ, Berlin AL. Rosacea – epidemiology and pathophysiology. In: Goldberg DJ, Berlin AL. Acne and rosacea. Epidemiology, diagnosis and treatment. London: Manson Publishing, 2013; p. 51-58.

Szlachcic A. The link between Helicobacter pylori infection and rosacea. J Eur Acad Dermatol Venereol 2002 Jul;16(4):328-33.

Ertl GA, Levine N, Kligman AM. A comparison of the effi- cacy of topical tretinoin and low-dose oral isotretinoin in rosacea. Arch Dermatol 1994 Mar;130(3):319-24.

Agnoletti AF, DE Col E, Parodi A, Schiavetti I, Savarino V, Rebora A, et al. Etiopathogenesis of rosacea: a prospective study with a three-year follow-up. G Ital Dermatol Venereol 2017 Oct;152(5):418-23.

Bhattarai S, Agrawal A, Rijal A, Majhi S, Pradhan B, Dhakal SS. The study of prevalence of Helicobacter pylori in patients with acne rosacea. Kathmandu Univ Med J (KUMJ) 2012 Oct-Dec;10(40):49-52.

Abadi ATB. Strategies used by Helicobacter pylori to establish persistent infection. World J Gastroenterol 2017 Apr 28;23(16):2870-82.

Saleh P, Naghavi-Behzad M, Babapour S, Piri R. The association between Helicobacter pylori infection and rosacea. Arch Clin Infect Dis 2018;13(1):e57740. DOI: 10.5812/ archcid.57740.

Lazaridou E, Korfitis C, Kemanetzi C, Sotiriou E, Apalla Z, Vakirlis E, et al. Rosacea and Helicobacter pylori: links and risks. Clin Cosmet Investig Dermatol 2017;10:305-10.

Kubanov A, Gallyamova Y, Kravchenko A. Clinical picture, diagnosis and treatment of rosacea, complicated by Demodex mites. Dermatol Reports 2019 Mar 28;11(1):7675. doi: 10.4081/dr.2019.7675.

Gonser LI, Gonser CE, Schaller M. [Erratum to: Pathogenesis, clinical picture, and current therapy of rosacea]. Hautarzt 2016;67(5):384. German. doi: 10.1007/s00105- 016-3786-2.

Logger JGM, de Vries FMC, van Erp PEJ, de Jong EMGJ, Peppelman M, Driessen RJB. Non-invasive objective skin measurement methods for rosacea assessment: a systematic review. Br J Dermatol 2020 Jan;182(1):55-66.

Egeberg A, Weinstock LB, Thyssen EP, Gislason GH, Thyssen JP. Rosacea and gastrointestinal disorders: a population-based cohort study. Br J Dermatol 2017 Jan;176(1):100-6.

Olazagasti J, Lynch P, Fazel N. The great mimickers of rosacea. Cutis 2014 Jul;94(1):39-45.

Tüzün Y, Wolf R. Red face revisited: II. Clin Dermatol 2014 Nov-Dec;32(6):709-10.

Rivero AL, Whitfeld M. An update on the treatment of rosacea. Aust Prescr 2018 Feb;41(1):20-4.

Baldwin HE. Systemic therapy for rosacea. Skin Therapy Lett 2007 Mar;12(2):1-5, 9.

Kubanov A, Gallyamova Y, Kravchenko A. Clinical picture, diagnosis and treatment of rosacea, complicated by Demodex mites. Dermatol Reports 2019 Mar 28;11(1):7675. doi: 10.4081/dr.2019.7675.

Griffiths C, Barker J, Bleiker T, Chalmers R, Creamer D. Rook’s Textbook of Dermatology 9th edition. London: John Wiley & Sons Ltd, 2016; p. 1851-1912.

Kong S, Amangai M, Bruckner A, Enk A, Margolis D, McMi- chael A, et al. Fitzpatrck’s dermatology in general medicine, 9th edition. New York: Mc Graw Hill Education Europe; 2019.

Jørgensen AR, Egeberg A, Gideonsson R, Weinstock LB, Thyssen EP, Thyssen JP. Rosacea is associated with Helicobacter pylori: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2017 Dec;31(12):2010-5.

Yang X. Relationship between Helicobacter pylori and rosacea: review and discussion. BMC Infect Dis 2018 Jul 11;18(1):318. doi: 10.1186/s12879-018-3232-4.

Hong J. Incidence and clinical significance of Helicobacter pylori associated protein antibody in peripheral blood of 39 patients with rosacea. Gui Zhou Med 2014;38(6):541-2.

Piri R. Comment on "Effects of Helicobacter pylori treat- ment on rosacea: A single-arm clinical trial study". J Dermatol 2017 Dec;44(12):e370. doi: 10.1111/1346- 8138.13999.

Saleh P, Naghavi-Behzad M, Herizchi H, Mokhtari F, Mirza-Aghazadeh-Attari M, Piri R. Effects of Helicobacter pylori treatment on rosacea: A single-arm clinical trial study. J Dermatol 2017 Sep;44(9):1033-7.

Herr H, You CH. Relationship between Helicobacter pylori and rosacea: it may be a myth. J Korean Med Sci Oct 2000;15(5):551-4.

Published
2021/09/30
Section
Original article